Insights from Davos: Web3 Consolidation Underway, Meta Alliance Launch, Web3 Reserve System
LONDON, May 17, 2022 – (ACN Newswire) – A consensus is emerging from multiple Davos…
News
ITC’s Trade Marketing and Distribution Transforms Warehouse and Labor Operations With Blue Yonder
KOLKATA, India & SCOTTSDALE, Ariz.–(BUSINESS WIRE)–ITC Limited, one of India’s leading marketers in the fast-moving…
MATRIXX Software Selected by StarHub for Real-Time Charging Capability to Power Digital Transformation and 5G Future
SINGAPORE & FOSTER CITY, Calif.–(BUSINESS WIRE)–#5G—MATRIXX Software, a global leader in 5G and real-time monetization…
Shareholder Alert: Did You Purchase Shares of Upstart Holdings, Inc. (UPST)? Robbins LLP Alerts Investors of Class Action Against Upstart Holdings, Inc.
SAN DIEGO–(BUSINESS WIRE)–$UPST #UPSTshareholders—The Class: Shareholder rights law firm Robbins LLP informs investors that a…
OKYO Pharma Limited Announces Pricing of Public Offering and Nasdaq Listing
LONDON, May 16, 2022 (GLOBE NEWSWIRE) — OKYO Pharma Limited (Nasdaq: OKYO, LSE: OKYO) (“OKYO…
UPSTART ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Upstart Holdings, Inc. and Encourages Investors to Contact the Firm
NEW YORK–(BUSINESS WIRE)–#Action–Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces…
IBM ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against International Business Machines Corporation and Encourages Investors to Contact the Firm
NEW YORK–(BUSINESS WIRE)–#Action–Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces…
Heliogen to Restate Full Year 2021 Financials
First Quarter 2022 Results and Conference Call Now Scheduled for May 23rd PASADENA, Calif.–(BUSINESS WIRE)–Heliogen,…
CANbridge-UMass Chan Medical School Gene Therapy Research Presented at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
First Study from CANbridge UMass Collaboration Shows Novel Gene Therapy Holds Promise for Spinal Muscular…
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Upstart Holdings, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of…
Innovative Industrial Properties Acquires Massachusetts Property and Enters Into Long-Term Lease with TILT
SAN DIEGO–(BUSINESS WIRE)–Innovative Industrial Properties, Inc. (IIP), the first and only real estate company on…
ABVC Biopharma Reports First Quarter 2022 Financial and Operational Results
FREMONT, CA, May 16, 2022 (GLOBE NEWSWIRE) — via NewMediaWire—ABVC BioPharma, Inc. (Nasdaq: ABVC), a clinical…
Aerovate Therapeutics Presents Phase 1 Data for AV-101, A Novel Dry Powder Inhaled Formulation of Imatinib Being Developed for the Treatment of Patients with Pulmonary Arterial Hypertension (PAH)
AV-101 is being developed to address cellular hyperproliferation and resistance to apoptosis in the pulmonary…
Preclinical Proof-of-Concept Data Supporting Future Clinical Development of Two New Cell Therapies Being Presented by Adaptimmune at ASGCT
– New next-gen SPEAR T-cells (ADP-A2M4N7X19) designed to enhance depth and durability of clinical response…
AnPac Bio Reports Fiscal Year 2021 Annual Financial Results
PHILADELPHIA, May 16, 2022 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company”…
Petros Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
NEW YORK, May 16, 2022 (GLOBE NEWSWIRE) — Petros Pharmaceuticals, Inc. (“Petros” or “the Company”)…
Athira Issues Statement in Response to Richard A. Kayne’s Suspension of His Proxy Contest
Athira Board Unanimously Recommends Shareholders Vote “FOR” its Highly Qualified Nominees – Joseph Edelman, John…
NightHawk Biosciences Provides First Quarter 2022 Business Update
DURHAM, N.C., May 16, 2022 (GLOBE NEWSWIRE) — NightHawk Biosciences (NYSE American: NHWK), a fully…
Adamis Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
Management to host webcast/conference call today at 2 p.m. PT / 5 p.m. ET SAN…
Biora Therapeutics to Participate in Upcoming H.C. Wainwright Global Investment Conference
SAN DIEGO, May 16, 2022 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech…